Figure-4:

Distribution of KRAS and BRAF mutations across CMS (4A) and correlation of CMS with overall survival (4B) in stage IV colorectal cancer.

Distribution of KRAS and BRAF mutations across CMS (4A) and correlation of CMS with overall survival (4B) in stage IV colorectal cancer.